|
 |
| CHI’s Genome Series of
conferences provides the most comprehensive coverage of genomic
advancements on the market.The development of high-throughput sequencing,
microarrays, and
other tools, in combination with the Human Genome Project,has resulted in genomic efforts becoming an essential component of
many therapeutic and diagnostic programs. Now with the draft of the human genome complete, much focus has been applied to
the genomics area. CHI remains on the pulse of the industry by continually updating conference programs and adding
new events that provides the industry with the leading resource for genomic information. |
|
|
|